ir.minervaneurosciences.com
Investors & Media - Minerva Neurosciences, Inc.
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Minerva Neurosciences, Inc.'s financial performance into perspective. Day High: 5.95. Day Low: 5.41. Aug 14, 2015. Delayed 20 min., by eSignal. Aug 5, 2015. Minerva Neurosciences Reports Second Quarter 2015 Financial Results and Business Updates. Jul 29, 2015. View all press releases ». Aug 5, 2015 at 8:30 AM ET. Jun 23, 2015 at 3:00 PM ET.
ir.mirait.co.jp
IR情報 | ミライト・ホールディングス
ir.missouri.edu
MU Institutional Research
MU Facts and Data Tables. The Office of Institutional Research and Quality Improvement advances the University's mission through the collection and analysis of data to inform decision making, planning and policy. The office provides planning and assessment consultation to facilitate and support continuous improvement. MU VSA College Portrait. Institutional Research and Quality Improvement. 721 Lewis Hall, Columbia, MO 65211. Phone: (573) 882-4077 • Fax: (573) 884-5545. An equal opportunity/ADA institution.
ir.mmpworldwideinc.com
TBG Holdings, Inc. - Innovative | Strategic | Growth
Train Travel Holdings Inc. Turnkey Home Buyers USA. What Is An Accredited Investor? Business Structure and Planning. Providing the Missing Pieces. Powerful Support for Growth. Welcome to TBG Holdings. Have you ever wished you were one of the first investors to put money into Facebook? When you call, ask about the Social Media Network currently under development.). Have you ever made an investment in a company that faded into silence after you wrote the check? Out of every 5 companies invested in:.
ir.mobi
ir.mobi is a Premium Name
Irmobi is a Premium Name. DotMobi is collecting expressions of interest in its Premium Names. At a future date, dotMobi will allocate these domains through the most appropriate option available and any plans will be announced in advance. To express your interest for ir.mobi. And be notified when it will be made available, please complete the form below (dotMobi will not make this information available to any third parties). Please check the required fields. News from Blog.mobi.
ir.mobimo.ch
Mobimo Holding AG - Porträt
Die Mobimo Holding AG besitzt folgende Beteiligungen. BSS&M Real Estate AG. FM Service and Dienstleistungs AG. Immobilien Invest Holding AG. LO Holding Lausanne-Ouchy SA. Mobimo Zürich Nord AG. Parking du Centre SA. Die Stimmanteile betragen 5%. Seestrasse 59 8700 Küsnacht Tel. 41 44 397 11 11.
ir.mocon.com
MOCON Inc. - Investor Relations
Quarterly and Annual Reports. Consulting and Testing Services. Aroma and Flavor Testing. CGMP Permeation Test Services. Standard Permeation Rate Testing. All Consulting and Testing Services. Don’t See Your Industry? MOCON Helps a Range of Industries. Quarterly and Annual Reports. Consulting and Testing Services. Aroma and Flavor Testing. CGMP Permeation Test Services. Standard Permeation Rate Testing. All Consulting and Testing Services. Minimum 20 minute delay. August 14, 2015. Past Events and Webcasts.
ir.mofcom.gov.cn
中华人民共和国驻伊朗伊斯兰共和国大使馆经济商务参赞处
伊朗印象之美丽的大布里士风光- - - -伊朗剪影 二十九. 伊朗印象之美丽的大布里士风光- - - -伊朗剪影 二十八. 伊朗印象之气势雄伟的亚兹德清真寺- - - -伊朗剪影 二十七. 伊朗印象之迷人的伊斯法罕- - - -伊朗剪影 二十六. 伊朗印象之迷人的伊斯法罕- - - -伊朗剪影 二十五. 2014年伊朗矿业及矿山机械博览会 MINEX 2014 将于10月14日开幕.
ir.mol.com
MOL - Investor Relations - Investor Home
Call Us: (603) 2082 1251. Stock Quote and Chart. Q2 2015 MOL Global Inc Earnings Conference Call. 160;at 8:00 am ET. Q2 2015 MOL Global Inc Earnings Conference Call. Friday, August 21, 2015 . 8:00 am ET . Through Friday, August 21, 2015 . Click here for webcast. Click here to add this event to your calendar. Q1 2015 MOL Global Inc Earnings Conference Call. MOL Global Inc First Quarter 2015 Financial Results. MOL Global Inc. to Announce Second Quarter 2015 Financial Results. 08/21/15 9:00 am ET. This cal...
ir.moleculin.com
Moleculin Biotech, Inc. (MBRX)
Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology. Annamycin vs. Daunorubicin. Management & Business Advisors. Partnerships & Collaborations. Dec 13, 2016. Quarter Ended Sep 30, 2016. Kirin M. Smith. VStock Transfer, LLC.
ir.moliyo.com
moliyo.com
邮箱: eName24@gmail.com QQ: 9596533.